BioLife Solutions Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
8,949.40
6,190.70
6,448.90
8,227.00
11,021.80
19,742
Cost of Goods Sold (COGS) incl. D&A
5,186.50
3,155.30
2,634.70
3,448.30
4,275.30
6,217
Gross Income
3,762.90
3,035.40
3,814.20
4,778.70
6,746.50
13,525
SG&A Expense
4,048.20
6,171.10
8,831.30
9,630.20
7,802.30
9,863
EBIT
285.40
3,135.70
5,017.10
4,851.50
1,055.90
3,662
Unusual Expense
-
-
-
2,872.60
67.70
-
Non Operating Income/Expense
-
4.40
-
1.20
-
-
Interest Expense
798.80
190.30
-
318.40
387.10
5
Pretax Income
1,084.20
3,300.80
4,995.40
8,041.40
2,515.10
3,266
Consolidated Net Income
1,084.20
3,300.80
4,995.40
8,041.40
2,515.10
3,266
Net Income
1,084.20
3,217.80
4,213.90
6,875.40
2,515.10
3,266
Net Income After Extraordinaries
1,084.20
3,217.80
4,213.90
6,875.40
2,515.10
3,266
Net Income Available to Common
1,084.20
3,217.80
4,213.90
6,875.40
2,727.60
2,927
EPS (Basic)
3.03
0.31
0.35
0.54
0.21
0.14
Basic Shares Outstanding
357.70
10,447.00
12,177.40
12,643.00
13,263.90
16,256.50
EPS (Diluted)
3.03
0.31
0.35
0.54
0.21
0.14
Diluted Shares Outstanding
357.70
10,447.00
12,177.40
12,643.00
13,263.90
21,627.30
EBITDA
38.30
2,877.60
4,673.90
4,483.40
717.20
4,000
Non-Operating Interest Income
-
20.80
21.80
2.40
0.40
281
Minority Interest Expense
-
83.00
781.40
1,165.90
-
-
Equity in Affiliates (Pretax)
-
-
-
-
1,004.90
672
Preferred Dividends
-
-
-
-
212.50
339
About BioLife Solutions
View Profile
